Sondra Smyrnios
Chief Tech/Sci/R&D Officer at ALKERMES PLC
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Richard Pops | M | 62 | 33 years | |
| Blair Jackson | M | 51 | 25 years | |
| David Gaffin | M | 52 | 8 years | |
| Shane Cooke | M | 61 | 13 years | |
| Declan O’Connor | M | - | 13 years | |
| Richard Gaynor | M | 74 | 5 years | |
| C. Nichols | M | - | 5 years | |
| Christopher Wright | M | 58 | 2 years | |
| Emily Alva | F | 49 | 3 years | |
| Cato Laurencin | M | 65 | 3 years | |
| Andy Wilson | M | 65 | 5 years | |
| Dave Daglio | M | - | 4 years | |
| Brian McKeon | M | 61 | 4 years | |
| Nancy Snyderman | M | 72 | 8 years | |
| Katie Joyce | F | - | - | |
| Stephen Schiavo | M | - | 6 years | |
| Kanchan Relwani | M | - | 7 years | |
| Anne Giovanoni | F | - | - | |
| Heather Faulds | F | - | 4 years | |
| Thomas Harvey | M | - | 19 years | |
| Peter Norman | M | - | 11 years | |
| Sandy Coombs | F | - | 15 years | |
| Craig Hopkinson | M | 56 | 7 years | |
| Michael Landine | M | 70 | 13 years | |
| Markus Haeberlein | M | - | - | |
| Niels Borgstein | M | - | 3 years | |
| Xin Zhao | M | 63 |
McGill University
| 31 years |
| Andrew McAusland | M | - |
Concordia University
| 34 years |
| Samuel Parisi | M | 49 | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Robert A. Breyer | M | 80 | 27 years | |
| Andrew Koven | M | 66 |
KOS Pharmaceuticals, Inc.
 KOS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology KOS Pharmaceuticals, Inc. operates as pharmaceutical company that developed and commercialized proprietary prescription products for the treatment of chronic cardiovascular, metabolic and respiratory diseases. The company is founded by Daniel M. Bell and Michael Jaharis in 1988 and is headquartered in Cranbury, NJ. | 3 years |
| Stephan Robert Patten | M | - |
McGill University
| 9 years |
| Jean Carrière | M | 55 |
Concordia University
| 6 years |
| Mark Monaghan | M | - |
McGill University
| 11 years |
| Wendy Dixon | M | 68 | 11 years | |
| Iain Brown | M | 55 | 21 years | |
| Philippe Dubuc | M | 57 |
Concordia University
McGill University
| 6 years |
| Paul J. Mitchell | M | 71 | 18 years | |
| Bijan Moazami | M | - |
McGill University
| 4 years |
| Adam Shine | M | - |
McGill University
| 7 years |
| Salvatore Ruscitti | M | - |
McGill University
| 8 years |
| Jovan Antunovic | M | - |
McGill University
| 4 years |
| Adrian Adams | M | 73 |
KOS Pharmaceuticals, Inc.
KOS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology KOS Pharmaceuticals, Inc. operates as pharmaceutical company that developed and commercialized proprietary prescription products for the treatment of chronic cardiovascular, metabolic and respiratory diseases. The company is founded by Daniel M. Bell and Michael Jaharis in 1988 and is headquartered in Cranbury, NJ. | 4 years |
| Jim Frates | M | 56 | 23 years | |
| Nancy Wysenski | F | 66 | 10 years | |
| Floyd E. Bloom | M | 87 | 8 years | |
| David Anstice | M | 75 | 14 years | |
| Khalid Husain | M | - |
McGill University
| 5 years |
| Jean Seguin | M | - |
McGill University
| 2 years |
| Jose M. Perez | M | 50 |
McGill University
| 4 years |
| Michael Stewart Shunock | M | - |
McGill University
| 4 years |
| Deirdre Quarnstrom | F | - |
McGill University
| 3 years |
| Brian Wynne Webster | M | - |
McGill University
| 4 years |
| Peter Hancock | M | 59 |
McGill University
| 3 years |
| Timothy Edward Lim | M | 49 |
McGill University
| 4 years |
| Stephan Brauer | M | - |
McGill University
| 3 years |
| Danielle Goldfarb | F | - |
McGill University
| 4 years |
| Ngai Au | M | 56 |
McGill University
| 2 years |
| Cyril Trouiller | M | - |
McGill University
| 1 years |
| Amal Khouri | F | - |
McGill University
| 4 years |
| Vi Hang Tran | M | 54 |
McGill University
| 4 years |
| Fredrik Orrenius | M | - |
McGill University
| 3 years |
| Carmine Marotta | M | - |
McGill University
| 4 years |
| Kwok Ki Chan | M | 51 |
McGill University
| 4 years |
| Steven M. Sonnenstein | M | - |
McGill University
| 5 years |
| Nicolas A. Pechet | M | 50 |
McGill University
| 4 years |
| Doug Sharp | M | 49 |
McGill University
| 4 years |
| Rebekah Young | F | - |
McGill University
| 4 years |
| Nick Wright | M | - |
McGill University
| 4 years |
| Chi Chung Hui | M | 49 |
McGill University
| 4 years |
| Mihai Buia | M | 57 |
McGill University
| 2 years |
| Neal Gilmer | M | - |
McGill University
| 4 years |
| Elliot J. Shapiro | M | - |
McGill University
| 4 years |
| Scott Yaphe | M | - |
McGill University
| 3 years |
| John Simmonds | M | 48 |
McGill University
| 4 years |
| William Pruitt | M | 83 |
KOS Pharmaceuticals, Inc.
KOS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology KOS Pharmaceuticals, Inc. operates as pharmaceutical company that developed and commercialized proprietary prescription products for the treatment of chronic cardiovascular, metabolic and respiratory diseases. The company is founded by Daniel M. Bell and Michael Jaharis in 1988 and is headquartered in Cranbury, NJ. | 2 years |
| Peggy McKay | F | 54 |
McGill University
| 4 years |
| Maxime Lemieux | M | - |
McGill University
| 4 years |
| François Carrier | M | - |
McGill University
| 4 years |
| Chad Williams | M | 58 |
McGill University
| 2 years |
| Bill Weaver | M | - |
McGill University
| 4 years |
| Harlan P. Carere | M | - |
McGill University
| 4 years |
| Mike Popowych | M | - |
McGill University
| 4 years |
| Joseph Abramson | M | - |
McGill University
| 3 years |
| Nancy Harrison | F | - |
McGill University
| 2 years |
| J. Bruce Robbins | M | - |
McGill University
| 2 years |
| Chris Kwan | M | - |
McGill University
| 4 years |
| Shawn Roland Kimel | M | - |
McGill University
| 4 years |
| Loki Jörgenson | M | 60 |
McGill University
| 3 years |
| Phil Marleau | M | 51 |
McGill University
| 4 years |
| William Tobman | M | - |
McGill University
| 4 years |
| Michael Yoon | M | - |
McGill University
| 4 years |
| William Reid Webb | M | - |
McGill University
| 2 years |
| Stefan Quenneville | M | - |
McGill University
| 4 years |
| Tanya S. Kanigan | M | - |
McGill University
| 3 years |
| Jonathan Craig | M | 52 |
McGill University
| 4 years |
| Jonathan B. Glass | M | - |
McGill University
| 4 years |
| Zhi He Li | M | 70 |
McGill University
| 1 years |
| Courtney Manning Oldrin | F | - |
McGill University
| 4 years |
| Adam Elliott | M | - |
McGill University
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Canada | 62 | 62.00% |
| Ireland | 35 | 35.00% |
| United States | 3 | 3.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Sondra Smyrnios
- Personal Network
